NYSE - Nasdaq Real Time Price USD

Hess Midstream LP (HESM)

Compare
41.35
+0.51
+(1.26%)
As of 1:35:53 PM EST. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 378.5M
Earnings 58.6M
Q4'23
Q1'24
Q2'24
Q3'24
0
100M
200M
300M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

39.00 Low
41.40 Average
41.35 Current
45.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 7677
Avg. Estimate 0.750.762.563.22
Low Estimate 0.480.482.291.98
High Estimate 1.021.022.794.35
Year Ago EPS 0.550.592.082.56

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 3355
Avg. Estimate 389.49M398.49M1.49B1.66B
Low Estimate 388.37M397.3M1.48B1.62B
High Estimate 390.31M399.59M1.5B1.69B
Year Ago Sales 356.5M355.6M1.35B1.49B
Sales Growth (year/est) 9.25%12.06%10.53%11.25%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.630.650.630.66
EPS Actual 0.550.590.590.63
Difference -0.08-0.06-0.04-0.03
Surprise % -12.29%-9.60%-6.91%-4.20%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.680.742.433.12
7 Days Ago 0.750.762.563.22
30 Days Ago 0.750.762.563.22
60 Days Ago 0.750.762.563.22
90 Days Ago 0.740.762.563.22

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days 1111
Down Last 30 Days 1111

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
HESM 35.59%28.20%22.94%25.73%
S&P 500 9.71%11.16%13.99%13.56%

Upgrades & Downgrades

Maintains JP Morgan: Neutral to Neutral 8/21/2024
Maintains UBS: Buy to Buy 7/3/2024
Maintains Wells Fargo: Equal-Weight to Equal-Weight 4/29/2024
Maintains JP Morgan: Neutral to Neutral 4/16/2024
Downgrade JP Morgan: Overweight to Neutral 3/8/2024
Maintains UBS: Buy to Buy 3/1/2024

Related Tickers